A recent study published in the Prostate Cancer and Prostatic Diseases evaluated focal therapy with high-intensity focused ...

The following is a summary of “Weaning of non COPD patients at high-risk of extubation failure assessed by lung ultrasound: ...

Used in conjunction with the oral sonosensitizing agent 5-ALA, the sonodynamic therapy led to a median OS of 15.7 months in ...

November 25, 2024icometrix' FDA-cleared quantitative brain solution for neurological conditions including Alzheimer's and multiple sclerosis is seamlessly integrated into Philips next generation ...

The procedure, using focused ultrasound technology, was performed at the Norton Neuroscience Institute, making it the first ...

The results from their first-in-human study demonstrated that median overall survival was doubled and progression-fr ...

Zapping the brain with ultrasound might cure addiction Scientists have grown tiny human brains in space to research new ...

Insightec received FDA approval for use with Philips MRI scanners. Insightec's Exablate Prime treats essential tremor and ...

Our Bureau, Mumbai Friday, November 22, 2024, 14:30 Hrs [IST] ...

Insightec announced today that it received FDA approval and CE mark for its Exablate Prime system with certain Philips MR ...

Insightec, a global healthcare company dedicated to using focused ultrasound to transform patient care, today announced the dual achievement of U.S. Food and Drug Administration (FDA) approval and CE ...

Neurological disorders such as Alzheimer's and Parkinson's disease are among the most debilitating and life-altering ...